NatMed Pro - References

15272

Kuriyan R, Raj T, Srinivas SK, et al. Effect of Caralluma Fimbriata extract on appetite, food intake and anthropometry in adult Indian men and women. Appetite 2007;48:338-44. View abstract.

15273

Gencor Pacific, Inc. New dietary ingredient notification: Caralluma fimbriata extract: Volumes 1-3. Notification to U.S. Food and Drug Administration, August 25, 2004. Available at: http://www.fda.gov/ohrms/dockets/dockets/95s0316/95s-0316-rpt0252-05-Caralluma-Fimbriata-Extract-vol184.pdf.

92083

Concalves JL, Lopes RC, Oliveira DB, et al. In vitro anti-rotavirus activity of some medicinal plants used in Brazil against diarrhea. J Ethnopharmacol 2005;99(3):403-7. View abstract.

94080

Arora E, Khajuria V, Tandon VR, et al. To evaluate efficacy and safety of Caralluma fimbriata in overweight and obese patients: a randomized, single blinded, placebo control trial. Perspect Clin Res 2015;6(1):39-44. View abstract.

94081

Griggs JL, Su XQ, Mathai ML. Caralluma fimbriata supplementation improves the appetite behavior of children and adolescents with Prader-Willi syndrome. N Am J Med Sci 2015;7(11):509-16. View abstract.

94082

Odendaal AY, Deshmukh NS, Marx TK, Schauss AG, Endres JR, Clewell AE. Safety assessment of a hydroethanolic extract of Caralluma fimbriata. Int J Toxicol 2013;32(5):385-94. View abstract.

94083

Adnan M, Jan S, Mussarat S, et al. A review on ethnobotany, phytochemistry and pharmacology of plant genus Caralluma R. Br. J Pharm Pharmacol 2014;66(10):1351-68. View abstract.

94084

GRAS Notice 000500: Hydroethanolic extract of Caralluma Fimbriata. https://www.fda.gov/downloads/Food/IngredientsPackagingLabeling/GRAS/NoticeInventory/ucm402152.pdf. Accessed July 9, 2017.

99999

Astell KJ, Mathai ML, McAinch AJ, Stathis CG, Su XQ. A pilot study investigating the effect of Caralluma fimbriata extract on the risk factors of metabolic syndrome in overweight and obese subjects: a randomised controlled clinical trial. Complement Ther Med. 2013;21(3):180-9. View abstract.

100000

Kell G, Rao A, Katsikitis M. A randomised placebo controlled clinical trial on the efficacy of Caralluma fimbriata supplement for reducing anxiety and stress in healthy adults over eight weeks. J Affect Disord. 2019;246:619-626. View abstract.

106437

Rao A, Briskey D, Dos Reis C, Mallard AR. The effect of an orally-dosed Caralluma Fimbriata extract on appetite control and body composition in overweight adults. Sci Rep 2021;11(1):6791. View abstract.

109492

Jayawardena R, Francis TV, Abhayaratna S, Ranasinghe P. The use of Caralluma fimbriata as an appetite suppressant and weight loss supplement: a systematic review and meta-analysis of clinical trials. BMC Complement Med Ther 2021;21(1):279. View abstract.